Optimization of follow-up MRI protocol for malignant neoplasms of the female pelvis

Introduction. MRI is widely used to follow-up malignant neoplasms of the female pelvis. Aim. To optimize the use of MRI sequences for follow-up of female patients with malignant pelvic neoplasms. Materials and methods. Retrospective analysis of female pelvic MRI has been performed on 1.5 T MR scanner. This study includes 530 protocols. Results. The authors describe different protocols for assessment and differential diagnosis of recurrence, postradiation and postoperative changes. It includes applicable sequences, axis and the structure which require evaluation. In all cases, dynamic follow-up has to include analysis of patient's previous studies, anamnesis, previous treatment, as well as the end of chemotherapy and radiotherapy. All of the above, combined with the oncologist's treatment of choice determines the objective of this study. Nowadays, MRI is the method which most accurately characterizes postoperative and postradiation structural changes. MRI is useful in detection of pelvic lymph nodes. The role of MRI has high potential in assessing the effectiveness of chemotherapy and radiation therapy. Conclusion. In order to make the optimal scan protocol, follow-up of malignant neoplasms of the pelvic organs in women require the use of clinical and anamnestic data along with the results of patient's previous studies. The combined use of various sequences and techniques can improve the diagnostic significance of pelvic MRI at follow-up. Contrast enhancement has additional role in diagnostics of recurrent of pelvic organs in women. The use of different contrast enhancement techniques has proven effective in case of postradiation and postoperative complications.

1. Sala E., Wakley S., Senior E., Lomas D. MRi of Malignant Neoplasms of the Uterine Corpus and Cervix // Amer. J. Roentgenol. 2007. Vol. 188. P. 1577-1587.

2. Rubtsova N.A., Novikova E.G., Antipov V.A., Novikova o.V., Puzakov K.V. Magnetic resonance imaging in diagnosis of recurrent cervical cancer after radical abdominal tracheоectomy. Siberian oncology journal, 2011, Vol. 5, No. 47, рр. 5-12 (in Russ.).

3. Marth C., Landoni F., Mahner S., McCormack M., Gonzalez-Martin A. Colombo N. Cervical cancer: ESMo Clinical Practice Guidelines for diagnosis, treatment and follow-up // Annals of Oncology. 2017. Vol. 28 (Suppl. 4). P. 72-83.

4. Trufanov G.E. Guidelines radiology in gynecology. St. Petersburg: Publishing house Elbi-SPb, 2008, 592 p. (In Russ.).

5. Delli Pizzi A., Basilico R., Cianci R., Seccia B., Timpani M., Tavoletta A., Caposiena D., Faricelli B., Gabrielli D., Caulo M. Rectal cancer MRi: protocols, signs and future perspectives radiologists should consider in everyday clinical practice // Insights Imaging. 2018. Vol. 9, No. 4. P. 405-412.

6. Kaprin A.D., Starinskiy V.V., Petrova G.V. Cancer status of issue health care to the population of Russia in 2017. Moscow: National Medical Research Radiology Centre, 2018, 236 p. (In Russ.).

7. Nougaret S., Horta M., Sala E., Lakhman Y., Thomassin-Naggara I., Kido A. Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology // European Radiology. 2019. Vol. 29 (2). P. 792-805.

8. Balleyguier C., Sala E., Da Cunha T., Bergman A., Brkljacic B., Danza F. Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology // European Radiology. 2011. Vol. 2 (5). P. 1102-1110.

9. Bergen T.A., Fokin V.A., Trufanov G.E. Systematization of the magnetic resonance protocol for primarily identified pelvic malignant masses in women. Diagnostic radiology and radiotherapy, 2019, No. 4, рр. 41-48 (In Russ.).